GGrantIndex
← Leaderboards

Barbara Laughton

Massachusetts General Hospital

$3,180,391
Attributed
$9,541,174
Total exposure
5
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,541,174 · 5

By mechanism

R01$9,254,173 · 4
R21$287,001 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Research focus

Africa South Of The SaharaSouth AfricaNeurodevelopmentChildNeuroimagingImageCohortMassachusettsUniversitiesSpectrum AnalysisMagnetic Resonance ImagingMorphometryBirthGeneral HospitalsBrain ImagingBrainCollaborationsChildhoodHiv InfectionsProgramsGray MatterMental DevelopmentAnti-Retroviral AgentsDiffusion Magnetic Resonance Imaging

Grant awards (22)

Neural correlates of in utero HIV and ART exposure: early childhood follow-up of a prospectively recruited cohort$249,545
R01 · FY2025 · HD
Neural correlates of in utero HIV and ART exposure: early childhood follow-up of a prospectively recruited cohort$209,938
R01 · FY2025 · HD
Neural correlates of in utero HIV and ART exposure: early childhood follow-up of a prospectively recruited cohort$117,578
R01 · FY2025 · HD
Neural correlates of in utero HIV and ART exposure: early childhood follow-up of a prospectively recruited cohort$590,497
R01 · FY2024 · HD
Neural correlates of in utero HIV and ART exposure: early childhood follow-up of a prospectively recruited cohort$652,205
R01 · FY2023 · HD
Extension of a longitudinal cognitive and brain imaging study of early-treated perinatally HIV infected children through adolescence$491,737
R01 · FY2023 · HD
Extension of a longitudinal cognitive and brain imaging study of early-treated perinatally HIV infected children through adolescence$490,028
R01 · FY2022 · HD
Extension of a longitudinal cognitive and brain imaging study of early-treated perinatally HIV infected children through adolescence$518,624
R01 · FY2021 · HD
Extension of a longitudinal cognitive and brain imaging study of early-treated perinatally HIV infected children through adolescence$566,542
R01 · FY2020 · HD
Neonatal imaging as an early marker of neurodevelopment and predictor of cognitive performance in infants exposed to HIV and ART in utero and perinatally$450,991
R01 · FY2020 · HD
Extension of a longitudinal cognitive and brain imaging study of early-treated perinatally HIV infected children through adolescence$632,178
R01 · FY2019 · HD
Neonatal imaging as an early marker of neurodevelopment and predictor of cognitive performance in infants exposed to HIV and ART in utero and perinatally$435,700
R01 · FY2019 · HD
Neonatal imaging as an early marker of neurodevelopment and predictor of cognitive performance in infants exposed to HIV and ART in utero and perinatally$456,404
R01 · FY2018 · HD
Neonatal imaging as an early marker of neurodevelopment and predictor of cognitive performance in infants exposed to HIV and ART in utero and perinatally$462,854
R01 · FY2017 · HD
Neonatal imaging as an early marker of neurodevelopment and predictor of cognitive performance in infants exposed to HIV and ART in utero and perinatally$537,079
R01 · FY2016 · HD
Longitudinal Neuroimaging and Cognitive Study of HIV-Infected Children$456,000
R01 · FY2015 · HD
Longitudinal Neuroimaging and Cognitive Study of HIV-Infected Children$449,942
R01 · FY2014 · HD
Longitudinal Neuroimaging and Cognitive Study of HIV-Infected Children$437,788
R01 · FY2013 · HD
Longitudinal Neuroimaging and Cognitive Study of HIV-Infected Children$498,642
R01 · FY2012 · HD
Technology development and neuroimaging for 5 year old children with HIV infectio$124,625
R21 · FY2012 · MH
Longitudinal Neuroimaging and Cognitive Study of HIV-Infected Children$549,901
R01 · FY2011 · HD
Technology development and neuroimaging for 5 year old children with HIV infectio$162,376
R21 · FY2011 · MH